NEO-STIM Trademark

Trademark Overview


On Thursday, June 14, 2018, a trademark application was filed for NEO-STIM with the United States Patent and Trademark Office. The USPTO has given the NEO-STIM trademark a serial number of 88000978. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2019. This trademark is owned by Neon Therapeutics, Inc.. The NEO-STIM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals

Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials
neo-stim

General Information


Serial Number88000978
Word MarkNEO-STIM
Filing DateThursday, June 14, 2018
Status700 - REGISTERED
Status DateTuesday, September 10, 2019
Registration Number5854519
Registration DateTuesday, September 10, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements


Amendment to a Registration/Renewal CertificateIssue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
Goods and ServicesMedical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 20, 2018
Primary Code042
First Use Anywhere DateFriday, March 2, 2018
First Use In Commerce DateFriday, March 2, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 20, 2018
Primary Code044
First Use Anywhere DateFriday, March 2, 2018
First Use In Commerce DateFriday, March 2, 2018

Trademark Owner History


Party NameBioNTech US Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameNeon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, October 1, 2018ASSIGNED TO EXAMINER
Tuesday, October 9, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 9, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 9, 2018NON-FINAL ACTION WRITTEN
Monday, June 18, 2018NEW APPLICATION ENTERED
Wednesday, June 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, May 19, 2019ASSIGNED TO LIE
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, January 6, 2022TEAS SECTION 7 REQUEST RECEIVED
Tuesday, April 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 3, 2022NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Thursday, June 2, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 10, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED